ARCHIVES

Oral Sorafenib Trial Published in The Lancet; Tablets Extend PFS in Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Eight applications Received For NSABP chairman

September 9, 1994

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title

February 9, 1990

O’Shaughnessy, Burris To Present for Genentech At FDA Hearing At June 28-29

June 10, 2011

$20 Million In Construction Funds Approved

April 2, 1976